Moody's Investors Service has affirmed Columbia, S.C.-based Palmetto Health's "Baa1" rating, affecting $484 million of debt.
The rating affirmation reflects a number of factors, including Palmetto's large size and important role in its market as an academic medical center and teaching hospital for Columbia-based University of South Carolina School of Medicine.
Palmetto Health also faces several challenges, including integration risks with a recently acquired hospital.
The outlook is stable, reflecting Moody's Investors Service's view that Palmetto will maintain operating performance at its current levels.
More articles on healthcare finance:
Coding error points to administrative glitch at St. Mark's Hospital
As hospitals increasingly hire oncologists, chemo costs rise
US annual spending on prescription drugs to reach $400 billion by 2020